Word

Status

Pending

Status Code

645

Status Date

Monday, April 29, 2024

Serial Number

90662885

Mark Type

3

Filing Date

Thursday, April 22, 2021

Trademark Owner History

D3 Bio (Wuxi) Co., Ltd.

Classifications

5 Pharmaceutical preparations for the treatment of respiratory diseases, cancer, musculoskeletal diseases, gastrointestinal disease, diseases and disorders related to the immune system, central nervous system, and cardiovascular system; chemico-pharmaceutical preparations for the treatment of respiratory diseases, cancer, musculoskeletal diseases, gastrointestinal disease, diseases and disorders related to the immune system, central nervous system, and cardiovascular system; drugs for medical purposes; pharmaceutical preparations for use in biomedicine; pharmaceutical drugs for the treatment of respiratory diseases; pharmaceutical drugs for the treatment of cancer; pharmaceutical preparation for treating musculoskeletal disorders; pharmaceutical preparation for treating gastrointestinal disease; pharmaceutical preparation for treating diseases and disorders related to the immune system; pharmaceutical preparation for the central nervous system; cardiovascular pharmaceutical drug preparation; none of the foregoing related to diagnostic preparations, diagnostic reagents, or diagnostic screening kits

The mark consists of the words "D3 BIO" in black all caps below three Chinese characters in red, all to the right of a rounded red zig-zag design centered on a red vertical line.
The non-Latin characters in the mark transliterate to "DeShengJi" and this means "Moral Rise Aid" in English.
D THREE BIO
The color(s) red and black is/are claimed as a feature of the mark.
"BIO"

Trademark Events

Apr 26, 2021

New Application Entered

Jul 28, 2021

New Application Office Supplied Data Entered

Jul 23, 2022

Assigned To Lie

Jul 29, 2021

Notice Of Design Search Code E-Mailed

Dec 17, 2021

Assigned To Examiner

Jan 5, 2022

Non-Final Action Written

Jan 5, 2022

Non-Final Action E-Mailed

Jan 5, 2022

Notification Of Non-Final Action E-Mailed

Jul 5, 2022

Teas Response To Office Action Received

Jul 25, 2022

Correspondence Received In Law Office

Jul 25, 2022

Teas/Email Correspondence Entered

Apr 29, 2024

Notification Of Final Refusal Emailed

Apr 29, 2024

Final Refusal E-Mailed

Apr 29, 2024

Final Refusal Written